dapsone has been researched along with Alveolitis, Fibrosing in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial disease of the lung tissue that causes symptoms such as coughing and asthma." | 1.72 | Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. ( Asgardoon, MH; Dehpour, AR; Derakhshan, MH; Noori, T; Sheibani, M; Shirooie, S; Tavangar, SM; Yousefi-Manesh, H, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yousefi-Manesh, H | 1 |
| Noori, T | 1 |
| Asgardoon, MH | 1 |
| Derakhshan, MH | 1 |
| Tavangar, SM | 1 |
| Sheibani, M | 1 |
| Shirooie, S | 1 |
| Dehpour, AR | 1 |
| Farouk, A | 1 |
| Salman, S | 1 |
2 other studies available for dapsone and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Protective effect of dapsone against bleomycin-induced lung fibrosis in rat.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bleomycin; Catalase; Dapsone; Disease Models, Anima | 2022 |
Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Chemotaxis, Leukocyte; Coronavirus Infections; COVID-19; | 2020 |